Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLP-1”

1,184 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,184 results

Early research (Phase 1)Study completedNCT00978900
What this trial is testing

Effects of Artificial Sweetener on Gastrointestinal (GI) Peptide Secretion

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 12
Not applicableUnknownNCT04232605
What this trial is testing

Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in Humans

Who this might be right for
Headache, Migraine
Danish Headache Center 43
Large-scale testing (Phase 3)UnknownNCT02718950
What this trial is testing

Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans

Who this might be right for
ObesityType 2 Diabetes Mellitus
University of Campinas, Brazil 20
Early research (Phase 1)Study completedNCT00823940
What this trial is testing

Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 42
Large-scale testing (Phase 3)Study completedNCT01607450
What this trial is testing

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Who this might be right for
Type 2 Diabetes MellitusHealthy
Indiana University 33
Post-approval studies (Phase 4)UnknownNCT00145353
What this trial is testing

Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

Who this might be right for
Type 1 Diabetes Mellitus
Odense University Hospital 16
Not applicableStudy completedNCT05177653
What this trial is testing

Separate and Combined Extrapancreatic Effects of the Incretin Hormones

Who this might be right for
Pancreatectomy; Hyperglycemia
University Hospital, Gentofte, Copenhagen 13
Post-approval studies (Phase 4)Study completedNCT02686177
What this trial is testing

Effect of GLP-1 on Angiogenesis

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 50
Early research (Phase 1)Study completedNCT01434901
What this trial is testing

The Effects of Bethanechol on Glucose Homeostasis

Who this might be right for
Type 2 Diabetes Mellitus
Washington University School of Medicine 50
Not applicableStudy completedNCT02475421
What this trial is testing

Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance

Who this might be right for
Diabetes
University Hospital, Gentofte, Copenhagen 32
Post-approval studies (Phase 4)Study completedNCT02340247
What this trial is testing

Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass

Who this might be right for
Severe Obesity
Hvidovre University Hospital 11
Not applicableLooking for participantsNCT07042672
What this trial is testing

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

Who this might be right for
Binge Eating Disorder Associated With ObesityBinge Eating DisorderEating Disorder Binge+4 more
Haukeland University Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT05254314
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Who this might be right for
Asthma
Vanderbilt University Medical Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT06411210
What this trial is testing

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

Who this might be right for
Diabetes type1Obesity
Yale University 54
Testing effectiveness (Phase 2)WithdrawnNCT03371862
What this trial is testing

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

Who this might be right for
Short Bowel Syndrome
Imperial College London
Not applicableStudy completedNCT00834938
What this trial is testing

Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

Who this might be right for
DiabetesBariatric SurgeryObesity
University of Campinas, Brazil 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06987513
What this trial is testing

RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Who this might be right for
Alcohol Use Disorder (AUD)
Altimmune, Inc. 100
Large-scale testing (Phase 3)Study completedNCT01879917
What this trial is testing

Liraglutide in Newly Onset Type 1 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 1
Hvidovre University Hospital 65
Early research (Phase 1)Study completedNCT02403648
What this trial is testing

Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons

Who this might be right for
Hypoglycemia
Biodel 15
Large-scale testing (Phase 3)Study completedNCT01558271
What this trial is testing

LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 492
Load More Results